|
Volumn 349, Issue 21, 2003, Pages 1987-1990
|
Immunologic Targets in Psoriasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEFACEPT;
CHEMOKINE;
CYTOKINE;
EFALIZUMAB;
ETANERCEPT;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
T LYMPHOCYTE RECEPTOR;
TUMOR NECROSIS FACTOR ALPHA;
ANTIGEN BINDING;
CELL SURFACE;
CLINICAL TRIAL;
DENDRITIC CELL;
DRUG EFFICACY;
ENTERITIS;
HUMAN;
IMMUNOLOGICAL PROCEDURES;
IMMUNOSURVEILLANCE;
LEUKOCYTE;
LYMPH NODE;
MOLECULAR DYNAMICS;
PRIORITY JOURNAL;
PSORIASIS;
PSORIATIC ARTHRITIS;
REVIEW;
RHEUMATOID ARTHRITIS;
SKIN BLOOD VESSEL;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD11A;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECOMBINANT FUSION PROTEINS;
T-LYMPHOCYTES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0344064197
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp038164 Document Type: Review |
Times cited : (88)
|
References (4)
|